TSG101 and leukemia: Rather than being deleted, the TSG101 protein is highly expressed in a range of human cancers, typically in association with aberrantly spliced transcripts, and TSG101 splice variants have been identified in leukemia as well as breast, cervical, lung, ovarian and prostate cancers [48,49,96,98,99,100].